Southern Medical University

Company snapshot

Administration building SMU library on main campus Southern Medical University (南方医科大学) is a provincial public medical university in [Baiyun](en.wikipedia.org/wiki/Baiyun,_Guangzhou), [Guangzhou](en.wikipedia.org/wiki/Guangzhou), [Guangdong](en.wikipedia.org/wiki/Guangdong), China. Formerly as a military-affiliated medical university, the whole institution was transferred to the Guangdong Provinci

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Southern Medical University. Not investment advice.

• What is Southern Medical University?

  Third Affiliated Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Multiple Myeloma. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USP

• Is Southern Medical University publicly traded?

  Southern Medical University appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Southern Medical University develop or market?

  We link 1 drug profile(s) where Southern Medical University is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/southern-xp-pty-ltd#company-drugs.

• What are the latest developments for Southern Medical University?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Southern Medical University focus on?

  Southern Medical University focuses on Multiple Myeloma based on our analysis of their pipeline programs and drug development activities.